EMA To Discuss Reactivating Landmark Clinical Trials Transparency Policy

 
• By Vibha Sharma

The European Medicines Agency will be looking at reviving its policy on proactive publishing of clinical study reports, which is currently suspended as the agency copes with huge staff losses on account of Brexit.  

Revival
EMA will explore when to revive its transparency policy • Source: Shutterstock

More from Europe

More from Geography